The role of DEAD-box helicases in cardiovascular diseases

Haiyang Ni1, Mingyu Wang1, QiZhu Tang1

  • 1Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, PR China; Hubei Key Laboratory of Metabolic and Chronic Diseases, Wuhan 430060, PR China.

Ageing Research Reviews
|December 26, 2025
PubMed

Insights

DEAD-box (DDX) helicases regulate RNA metabolism and cellular processes. Emerging research highlights their significant roles in the pathogenesis of cardiovascular diseases (CVDs).

Area of Science:

  • Molecular Biology
  • Cardiology
  • Genetics

Background:

  • Cardiovascular diseases (CVDs) are a major global health concern, driven by complex factors like metabolic dysfunction, vascular issues, and inflammation.
  • DEAD-box (DDX) helicases, a family of RNA helicases, are crucial for RNA metabolism, influencing transcription, splicing, translation, and degradation.
  • These helicases are involved in fundamental cellular functions, including proliferation, immunity, and stress responses.

Purpose of the Study:

  • To explore the emerging roles of DEAD-box (DDX) helicases in the pathogenesis of cardiovascular diseases (CVDs).
  • To understand how DDX helicases contribute to the molecular mechanisms underlying CVDs.

Main Methods:

  • Review of current literature on DEAD-box (DDX) helicases and their functions.
  • Analysis of studies investigating the involvement of RNA helicases in cardiovascular pathophysiology.
  • Integration of findings on RNA metabolism and cellular processes regulated by DDX helicases in the context of CVDs.

Main Results:

  • DDX helicases are recognized as key regulators of RNA metabolism, essential for maintaining cellular homeostasis.
  • Evidence suggests DDX helicases participate in cellular processes directly relevant to CVD development, such as inflammation and stress responses.
  • Specific DDX helicases are increasingly implicated in the pathological mechanisms of cardiovascular diseases.

Conclusions:

  • DEAD-box (DDX) helicases represent a significant area of research with potential implications for understanding and treating cardiovascular diseases.
  • Further investigation into the specific functions and regulatory mechanisms of DDX helicases in CVD pathogenesis is warranted.
  • Targeting DDX helicase activity could offer novel therapeutic strategies for cardiovascular conditions.

Related Concept Videos

DNA Helicases00:55

DNA Helicases

DNA unwinding helicase enzymes are a type of motor protein. Motor proteins can translocate along filaments or polymers using energy generated from ATP hydrolysis. Helicases are involved in all the important cellular processes where DNA unwinding is required, such as DNA replication, repair, recombination, and transcription. They are present in all living organisms, but vary in their structure, function, and mechanism of action. For example, in prokaryotes, DnaB helicase binds and translocates...
23.7K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.0K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
360
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
336
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
846
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.3K